TrialBritish journal of cancer2017

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.

Heikki Joensuu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.